

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * cellular response to type I interferon (GO:0071357) | 7.32175921 |
| 2 | * type I interferon signaling pathway (GO:0060337) | 7.32175921 |
| 3 | * response to type I interferon (GO:0034340) | 7.23165451 |
| 4 | response to interferon-alpha (GO:0035455) | 6.20148072 |
| 5 | negative regulation of viral genome replication (GO:0045071) | 6.04878739 |
| 6 | cellular response to interferon-alpha (GO:0035457) | 5.47184398 |
| 7 | response to interferon-beta (GO:0035456) | 5.34674104 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.90562925 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.81766159 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.51624290 |
| 11 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.29528624 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.24678252 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.05804401 |
| 14 | regulation of interferon-alpha production (GO:0032647) | 4.03765847 |
| 15 | regulation of viral genome replication (GO:0045069) | 4.01218394 |
| 16 | negative regulation of viral process (GO:0048525) | 3.96566901 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 3.90652916 |
| 18 | cellular response to exogenous dsRNA (GO:0071360) | 3.84613061 |
| 19 | cellular response to interferon-beta (GO:0035458) | 3.76495522 |
| 20 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.71180755 |
| 21 | defense response to virus (GO:0051607) | 3.61904228 |
| 22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.55147082 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.54968357 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.54968357 |
| 25 | response to peptidoglycan (GO:0032494) | 3.54821045 |
| 26 | cellular response to virus (GO:0098586) | 3.52653871 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 3.46210335 |
| 28 | cellular response to interferon-gamma (GO:0071346) | 3.43276167 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.42629477 |
| 30 | response to interferon-gamma (GO:0034341) | 3.39542505 |
| 31 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.31855824 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20162442 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.18903276 |
| 34 | detection of other organism (GO:0098543) | 3.18308823 |
| 35 | detection of bacterium (GO:0016045) | 3.17164033 |
| 36 | positive regulation of type 2 immune response (GO:0002830) | 3.15769594 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 3.05814505 |
| 38 | interferon-gamma secretion (GO:0072643) | 3.04486803 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 3.00445651 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 3.00445651 |
| 41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.00445651 |
| 42 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.00445651 |
| 43 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.00445651 |
| 44 | modulation by symbiont of host immune response (GO:0052553) | 3.00445651 |
| 45 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00205704 |
| 46 | B cell mediated immunity (GO:0019724) | 2.98272266 |
| 47 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.95770273 |
| 48 | regulation of mononuclear cell migration (GO:0071675) | 2.95507314 |
| 49 | positive regulation of interferon-beta production (GO:0032728) | 2.91723775 |
| 50 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.90975338 |
| 51 | regulation of type 2 immune response (GO:0002828) | 2.90395775 |
| 52 | negative regulation of type I interferon production (GO:0032480) | 2.88696997 |
| 53 | myeloid dendritic cell differentiation (GO:0043011) | 2.88137046 |
| 54 | lymphocyte chemotaxis (GO:0048247) | 2.86852806 |
| 55 | regulation of antigen processing and presentation (GO:0002577) | 2.85887322 |
| 56 | T cell migration (GO:0072678) | 2.85402025 |
| 57 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.85396428 |
| 58 | positive regulation of antigen processing and presentation (GO:0002579) | 2.82956048 |
| 59 | regulation of chemokine biosynthetic process (GO:0045073) | 2.81913965 |
| 60 | detection of external biotic stimulus (GO:0098581) | 2.81843824 |
| 61 | neutrophil activation involved in immune response (GO:0002283) | 2.80353650 |
| 62 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78989628 |
| 63 | negative regulation of innate immune response (GO:0045824) | 2.78398878 |
| 64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.77931584 |
| 65 | eosinophil chemotaxis (GO:0048245) | 2.74487285 |
| 66 | regulation of T cell tolerance induction (GO:0002664) | 2.73825869 |
| 67 | negative regulation of viral entry into host cell (GO:0046597) | 2.72216501 |
| 68 | response to host immune response (GO:0052572) | 2.66341823 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66341823 |
| 70 | positive regulation of defense response to virus by host (GO:0002230) | 2.65849685 |
| 71 | response to protozoan (GO:0001562) | 2.65447850 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 2.64939666 |
| 73 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.64795014 |
| 74 | negative regulation of multi-organism process (GO:0043901) | 2.62878468 |
| 75 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.62663207 |
| 76 | defense response to protozoan (GO:0042832) | 2.62449274 |
| 77 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.61865823 |
| 78 | negative regulation of defense response to virus (GO:0050687) | 2.61738587 |
| 79 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.60296151 |
| 80 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.59711050 |
| 81 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.59097747 |
| 82 | amino sugar catabolic process (GO:0046348) | 2.58235000 |
| 83 | germinal center formation (GO:0002467) | 2.55185535 |
| 84 | regulation of defense response to virus by host (GO:0050691) | 2.54446877 |
| 85 | granulocyte activation (GO:0036230) | 2.53892708 |
| 86 | myeloid dendritic cell activation (GO:0001773) | 2.53404063 |
| 87 | regulation of viral entry into host cell (GO:0046596) | 2.52834502 |
| 88 | response to exogenous dsRNA (GO:0043330) | 2.52761938 |
| 89 | regulation of chronic inflammatory response (GO:0002676) | 2.51774257 |
| 90 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.51620708 |
| 91 | regulation of RIG-I signaling pathway (GO:0039535) | 2.50055200 |
| 92 | T-helper 1 type immune response (GO:0042088) | 2.49871814 |
| 93 | positive regulation of lymphocyte migration (GO:2000403) | 2.47554809 |
| 94 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.47523381 |
| 95 | response to virus (GO:0009615) | 2.47162745 |
| 96 | regulation of lymphocyte migration (GO:2000401) | 2.46078998 |
| 97 | negative regulation of type 2 immune response (GO:0002829) | 2.46069683 |
| 98 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.45582241 |
| 99 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.45570182 |
| 100 | response to host defenses (GO:0052200) | 2.44895707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.58060911 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.32732747 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.17334563 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.93526316 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.38407607 |
| 6 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.04829724 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.85024835 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.59370509 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.40168440 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.38594548 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33653062 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29325282 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12716357 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.09222179 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05136530 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97797658 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.95515829 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92823734 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.92430428 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89684222 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89323556 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84860448 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81797630 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76629988 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 1.71842841 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65836691 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.65822131 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.64138315 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64125615 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.57952969 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56346461 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55520920 |
| 33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55399483 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55348246 |
| 35 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.52959014 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48629068 |
| 37 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48599333 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47536735 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45688405 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.45411671 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44797665 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36450026 |
| 43 | * MAF_26560356_Chip-Seq_TH2_Human | 1.35751471 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32211230 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28807639 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28547398 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26265795 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25242252 |
| 49 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.25046360 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23485973 |
| 51 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23449458 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22878230 |
| 53 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21778367 |
| 54 | * MYB_26560356_Chip-Seq_TH2_Human | 1.20897910 |
| 55 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20877535 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18685768 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17301901 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15646623 |
| 59 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15365996 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15302235 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13991791 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13822259 |
| 63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12995393 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12754163 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11606335 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10678515 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09107525 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08432108 |
| 69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08169087 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07440238 |
| 71 | * MYB_26560356_Chip-Seq_TH1_Human | 1.05177078 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03438040 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03240178 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01475935 |
| 75 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.01047714 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99348797 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98890822 |
| 78 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98248063 |
| 79 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97821582 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96595179 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96295482 |
| 82 | MYC_22102868_ChIP-Seq_BL_Human | 0.96149341 |
| 83 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.95740906 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95643543 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95491280 |
| 86 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95410799 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95134630 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93879737 |
| 89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93460502 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93144734 |
| 91 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92668105 |
| 92 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92212621 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91596600 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90930311 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90197706 |
| 96 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90110472 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89746561 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89724260 |
| 99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89008112 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88960689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.77587079 |
| 2 | MP0009785_altered_susceptibility_to | 3.71477820 |
| 3 | MP0006082_CNS_inflammation | 3.64485280 |
| 4 | MP0003724_increased_susceptibility_to | 3.55820046 |
| 5 | MP0003303_peritoneal_inflammation | 3.19988021 |
| 6 | MP0003436_decreased_susceptibility_to | 3.16081843 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.08164265 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.05633735 |
| 9 | MP0005025_abnormal_response_to | 2.79215207 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.74141175 |
| 11 | MP0005671_abnormal_response_to | 2.72537942 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.67002487 |
| 13 | MP0005387_immune_system_phenotype | 2.59182454 |
| 14 | MP0001790_abnormal_immune_system | 2.59182454 |
| 15 | MP0002419_abnormal_innate_immunity | 2.43832738 |
| 16 | MP0009840_abnormal_foam_cell | 2.42706576 |
| 17 | MP0004510_myositis | 2.29163225 |
| 18 | MP0000685_abnormal_immune_system | 2.24193279 |
| 19 | MP0002723_abnormal_immune_serum | 2.20896039 |
| 20 | MP0001800_abnormal_humoral_immune | 2.15624779 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.15397006 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.10193299 |
| 23 | MP0003075_altered_response_to | 2.07375105 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.05172442 |
| 25 | MP0000343_altered_response_to | 1.93647884 |
| 26 | MP0004947_skin_inflammation | 1.89336106 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.84494240 |
| 28 | MP0001819_abnormal_immune_cell | 1.84455484 |
| 29 | MP0000604_amyloidosis | 1.81733159 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.75914388 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.74719463 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.74213908 |
| 33 | MP0008469_abnormal_protein_level | 1.71010379 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.69518155 |
| 35 | MP0005451_abnormal_body_composition | 1.65611281 |
| 36 | MP0009764_decreased_sensitivity_to | 1.61994521 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.53027585 |
| 38 | MP0001853_heart_inflammation | 1.50775056 |
| 39 | MP0000858_altered_metastatic_potential | 1.47808784 |
| 40 | MP0003448_altered_tumor_morphology | 1.47106472 |
| 41 | MP0001542_abnormal_bone_strength | 1.46016404 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.44013152 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.39944216 |
| 44 | MP0005166_decreased_susceptibility_to | 1.38463286 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.37917806 |
| 46 | MP0008438_abnormal_cutaneous_collagen | 1.36479677 |
| 47 | MP0002405_respiratory_system_inflammati | 1.36140682 |
| 48 | MP0000716_abnormal_immune_system | 1.31398662 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.31046689 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.30150475 |
| 51 | MP0002933_joint_inflammation | 1.28409814 |
| 52 | MP0009278_abnormal_bone_marrow | 1.27441849 |
| 53 | MP0005310_abnormal_salivary_gland | 1.25284731 |
| 54 | MP0003329_amyloid_beta_deposits | 1.20900544 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.20445747 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.19356718 |
| 57 | MP0005390_skeleton_phenotype | 1.11418829 |
| 58 | MP0008260_abnormal_autophagy | 1.10679805 |
| 59 | MP0005164_abnormal_response_to | 1.08944270 |
| 60 | MP0002398_abnormal_bone_marrow | 1.08914979 |
| 61 | MP0003045_fibrosis | 1.08814696 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.08728211 |
| 63 | MP0005023_abnormal_wound_healing | 1.08645415 |
| 64 | MP0003690_abnormal_glial_cell | 1.05765778 |
| 65 | MP0009763_increased_sensitivity_to | 1.03632473 |
| 66 | MP0003279_aneurysm | 1.02470511 |
| 67 | MP0002254_reproductive_system_inflammat | 1.02185585 |
| 68 | MP0005165_increased_susceptibility_to | 1.01588755 |
| 69 | MP0002429_abnormal_blood_cell | 0.98546835 |
| 70 | MP0006054_spinal_hemorrhage | 0.96361193 |
| 71 | MP0004883_abnormal_blood_vessel | 0.96124574 |
| 72 | MP0001958_emphysema | 0.94158162 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 0.93902066 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.93902066 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.91561812 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.91057220 |
| 77 | MP0003866_abnormal_defecation | 0.89866334 |
| 78 | MP0003795_abnormal_bone_structure | 0.89248198 |
| 79 | MP0000689_abnormal_spleen_morphology | 0.88213352 |
| 80 | MP0002332_abnormal_exercise_endurance | 0.87466385 |
| 81 | MP0003091_abnormal_cell_migration | 0.86512853 |
| 82 | MP0002722_abnormal_immune_system | 0.83417014 |
| 83 | MP0002006_tumorigenesis | 0.80772673 |
| 84 | MP0001873_stomach_inflammation | 0.80211875 |
| 85 | MP0000920_abnormal_myelination | 0.79780970 |
| 86 | MP0008874_decreased_physiological_sensi | 0.77680610 |
| 87 | MP0005257_abnormal_intraocular_pressure | 0.73011162 |
| 88 | MP0001243_abnormal_dermal_layer | 0.71444195 |
| 89 | MP0004381_abnormal_hair_follicle | 0.67844402 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.67810189 |
| 91 | MP0003186_abnormal_redox_activity | 0.67786199 |
| 92 | MP0000249_abnormal_blood_vessel | 0.66671254 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.62637474 |
| 94 | MP0003195_calcinosis | 0.61072700 |
| 95 | MP0008004_abnormal_stomach_pH | 0.60140391 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.60036347 |
| 97 | MP0001216_abnormal_epidermal_layer | 0.59900548 |
| 98 | MP0003879_abnormal_hair_cell | 0.58758903 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.57426318 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.54667904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.65101863 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.65101863 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.65101863 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.63648869 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.24806433 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.12191578 |
| 7 | Orchitis (HP:0100796) | 3.93110310 |
| 8 | Myositis (HP:0100614) | 3.86386309 |
| 9 | Loss of speech (HP:0002371) | 3.85916130 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.85095114 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.81879524 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.81411430 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.69342139 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.66322368 |
| 15 | Optic neuritis (HP:0100653) | 3.66322368 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.40911259 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.33803553 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.24902514 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.16785431 |
| 20 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.16785431 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.16785431 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.16644162 |
| 23 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.99465477 |
| 24 | Mucopolysacchariduria (HP:0008155) | 2.99465477 |
| 25 | Recurrent skin infections (HP:0001581) | 2.88794538 |
| 26 | Recurrent fungal infections (HP:0002841) | 2.86017390 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.84852252 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 2.84852252 |
| 29 | Vertebral compression fractures (HP:0002953) | 2.83453031 |
| 30 | Vasculitis (HP:0002633) | 2.83177394 |
| 31 | Pulmonary infiltrates (HP:0002113) | 2.81857256 |
| 32 | Stomatitis (HP:0010280) | 2.80818266 |
| 33 | Progressive neurologic deterioration (HP:0002344) | 2.75545724 |
| 34 | Recurrent viral infections (HP:0004429) | 2.75221468 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73131856 |
| 36 | Hypergammaglobulinemia (HP:0010702) | 2.70047686 |
| 37 | Increased IgM level (HP:0003496) | 2.68869951 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.67157224 |
| 39 | Gingivitis (HP:0000230) | 2.65377201 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.64959098 |
| 41 | Obstructive lung disease (HP:0006536) | 2.62042714 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.62042714 |
| 43 | Meningitis (HP:0001287) | 2.59712331 |
| 44 | Hemoptysis (HP:0002105) | 2.58853336 |
| 45 | Purpura (HP:0000979) | 2.51004037 |
| 46 | Glomerulonephritis (HP:0000099) | 2.47961070 |
| 47 | Basal ganglia calcification (HP:0002135) | 2.43609237 |
| 48 | Abnormality of the nasal mucosa (HP:0000433) | 2.43199522 |
| 49 | Increased serum ferritin (HP:0003281) | 2.39801353 |
| 50 | Hepatosplenomegaly (HP:0001433) | 2.36799372 |
| 51 | Neurofibrillary tangles (HP:0002185) | 2.31673082 |
| 52 | Axonal loss (HP:0003447) | 2.31219697 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.30686949 |
| 54 | Petechiae (HP:0000967) | 2.29586852 |
| 55 | T lymphocytopenia (HP:0005403) | 2.29192489 |
| 56 | Nasal polyposis (HP:0100582) | 2.28009747 |
| 57 | Abnormality of the pericardium (HP:0001697) | 2.27998847 |
| 58 | J-shaped sella turcica (HP:0002680) | 2.27713498 |
| 59 | Gastrointestinal infarctions (HP:0005244) | 2.25632800 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 2.25556912 |
| 61 | Abnormality of T cell number (HP:0011839) | 2.23416016 |
| 62 | Complement deficiency (HP:0004431) | 2.21883680 |
| 63 | Amyloidosis (HP:0011034) | 2.21737134 |
| 64 | Emphysema (HP:0002097) | 2.20760255 |
| 65 | Cellulitis (HP:0100658) | 2.18334563 |
| 66 | Urticaria (HP:0001025) | 2.17801169 |
| 67 | Chronic otitis media (HP:0000389) | 2.17272991 |
| 68 | Abnormality of complement system (HP:0005339) | 2.16700081 |
| 69 | Prolonged neonatal jaundice (HP:0006579) | 2.16104183 |
| 70 | Increased IgE level (HP:0003212) | 2.14849069 |
| 71 | Nuclear cataract (HP:0100018) | 2.14044389 |
| 72 | Disinhibition (HP:0000734) | 2.11020669 |
| 73 | Cervical subluxation (HP:0003308) | 2.08774183 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.03028396 |
| 75 | Arterial thrombosis (HP:0004420) | 2.02996360 |
| 76 | Bone pain (HP:0002653) | 2.02039030 |
| 77 | Keratoconjunctivitis (HP:0001096) | 2.01825094 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 1.99478877 |
| 79 | Gangrene (HP:0100758) | 1.98663997 |
| 80 | Encephalitis (HP:0002383) | 1.97198908 |
| 81 | Autoimmune hemolytic anemia (HP:0001890) | 1.97130699 |
| 82 | Abnormality of iron homeostasis (HP:0011031) | 1.94969439 |
| 83 | Distal lower limb muscle weakness (HP:0009053) | 1.94189931 |
| 84 | Restrictive lung disease (HP:0002091) | 1.94114558 |
| 85 | Abnormality of the pleura (HP:0002103) | 1.92742496 |
| 86 | Cheilitis (HP:0100825) | 1.88085682 |
| 87 | Asymmetric septal hypertrophy (HP:0001670) | 1.86635981 |
| 88 | Cardiomegaly (HP:0001640) | 1.86321513 |
| 89 | Cerebral inclusion bodies (HP:0100314) | 1.84288519 |
| 90 | Arthralgia (HP:0002829) | 1.83309466 |
| 91 | Malnutrition (HP:0004395) | 1.83279070 |
| 92 | Joint swelling (HP:0001386) | 1.82970921 |
| 93 | Pulmonary embolism (HP:0002204) | 1.81431635 |
| 94 | Peritonitis (HP:0002586) | 1.81421082 |
| 95 | Premature loss of primary teeth (HP:0006323) | 1.80785256 |
| 96 | Nephritis (HP:0000123) | 1.80291758 |
| 97 | Glomerulopathy (HP:0100820) | 1.78111150 |
| 98 | Chest pain (HP:0100749) | 1.77760913 |
| 99 | Polyneuropathy (HP:0001271) | 1.76277979 |
| 100 | Pathologic fracture (HP:0002756) | 1.75909155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 3.62732367 |
| 2 | ERN1 | 3.17222455 |
| 3 | TBK1 | 3.03890581 |
| 4 | IKBKE | 3.00865916 |
| 5 | IRAK3 | 2.78568785 |
| 6 | NME2 | 2.76453224 |
| 7 | FGFR4 | 2.67422286 |
| 8 | MAP4K1 | 2.51157621 |
| 9 | JAK3 | 2.47201328 |
| 10 | JAK1 | 2.40678713 |
| 11 | BLK | 2.32533563 |
| 12 | RIPK4 | 2.07403502 |
| 13 | KIT | 2.02572030 |
| 14 | TESK2 | 1.96981253 |
| 15 | IRAK4 | 1.94828523 |
| 16 | MAP3K11 | 1.90914752 |
| 17 | GRK7 | 1.89811982 |
| 18 | MAP3K14 | 1.85196530 |
| 19 | TRIB3 | 1.84991859 |
| 20 | RIPK1 | 1.84771868 |
| 21 | TESK1 | 1.80423844 |
| 22 | MAP3K3 | 1.75888237 |
| 23 | ZAP70 | 1.70027271 |
| 24 | CSK | 1.62652726 |
| 25 | PIM2 | 1.60774118 |
| 26 | TXK | 1.56602424 |
| 27 | IKBKB | 1.49912919 |
| 28 | TAOK2 | 1.49472396 |
| 29 | EPHB1 | 1.40497258 |
| 30 | SIK1 | 1.39731903 |
| 31 | PRPF4B | 1.39426412 |
| 32 | DDR2 | 1.34017741 |
| 33 | SMG1 | 1.32319153 |
| 34 | TAOK1 | 1.27227156 |
| 35 | EPHA2 | 1.25779558 |
| 36 | MAPKAPK3 | 1.25261400 |
| 37 | FGFR3 | 1.19574889 |
| 38 | MATK | 1.19144817 |
| 39 | MAP2K3 | 1.18050776 |
| 40 | TGFBR2 | 1.16475336 |
| 41 | TNK2 | 1.16368295 |
| 42 | CSF1R | 1.10348662 |
| 43 | JAK2 | 1.02377258 |
| 44 | SYK | 0.93884734 |
| 45 | CDC42BPA | 0.93294965 |
| 46 | MAP3K1 | 0.92808509 |
| 47 | LCK | 0.89420234 |
| 48 | HIPK2 | 0.86950721 |
| 49 | FES | 0.85969564 |
| 50 | LYN | 0.85120703 |
| 51 | MAPK11 | 0.84674539 |
| 52 | CHUK | 0.82770289 |
| 53 | SCYL2 | 0.82721219 |
| 54 | BTK | 0.80909282 |
| 55 | GRK6 | 0.78938522 |
| 56 | MOS | 0.78672999 |
| 57 | ABL2 | 0.78394381 |
| 58 | PAK4 | 0.78144039 |
| 59 | MAP3K13 | 0.78126668 |
| 60 | FGR | 0.77642842 |
| 61 | PRKD2 | 0.77065177 |
| 62 | ARAF | 0.74422348 |
| 63 | DAPK3 | 0.72198418 |
| 64 | KDR | 0.71630319 |
| 65 | BCKDK | 0.71243399 |
| 66 | LIMK1 | 0.70024439 |
| 67 | PKN2 | 0.64256502 |
| 68 | HCK | 0.63298600 |
| 69 | BMPR2 | 0.62736283 |
| 70 | FER | 0.59255197 |
| 71 | NEK9 | 0.59086236 |
| 72 | LRRK2 | 0.57177597 |
| 73 | ITK | 0.56345164 |
| 74 | PDPK1 | 0.55056075 |
| 75 | MAPK7 | 0.54344692 |
| 76 | ADRBK2 | 0.53070700 |
| 77 | MAP2K6 | 0.51484703 |
| 78 | BMX | 0.49413533 |
| 79 | EPHA3 | 0.48044573 |
| 80 | IRAK1 | 0.46552637 |
| 81 | PTK6 | 0.46399204 |
| 82 | PDK1 | 0.45624835 |
| 83 | PRKCD | 0.45178529 |
| 84 | RPS6KA2 | 0.42277496 |
| 85 | ABL1 | 0.41054571 |
| 86 | CAMK2G | 0.40743233 |
| 87 | MAPKAPK2 | 0.39961726 |
| 88 | MUSK | 0.39580842 |
| 89 | IRAK2 | 0.36277696 |
| 90 | STK10 | 0.34798648 |
| 91 | SIK3 | 0.33700703 |
| 92 | FYN | 0.33678398 |
| 93 | DAPK2 | 0.32763965 |
| 94 | MAP2K2 | 0.31633137 |
| 95 | TTN | 0.31392386 |
| 96 | RPS6KA5 | 0.30919285 |
| 97 | MAPK4 | 0.30836321 |
| 98 | PRKCQ | 0.30468849 |
| 99 | MARK3 | 0.29962299 |
| 100 | PRKD1 | 0.29929519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 2.94398439 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.72396201 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.69527442 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.68117833 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.63690719 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.62138081 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.56808397 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.39798913 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.37838294 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37622398 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.25260615 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.23933561 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 2.17580816 |
| 14 | Influenza A_Homo sapiens_hsa05164 | 2.15067367 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.10476309 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09280641 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.07682158 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99615378 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97363676 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.97297445 |
| 21 | Hepatitis C_Homo sapiens_hsa05160 | 1.90988836 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.89703752 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87591286 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.84880851 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.81791142 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.81489498 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.63572882 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.60216963 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51922760 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.48815767 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42348061 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.40240500 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40017810 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37816924 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37438429 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.33375453 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30108837 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.29262925 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27282646 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23600261 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14719801 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12607564 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 1.12455980 |
| 44 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.10121453 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09467640 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.06782588 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06383441 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.01385253 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95847707 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92107627 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91775215 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.87489567 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.84527868 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83739478 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83270353 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 0.79298796 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79278530 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78636993 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.74217864 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69403521 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68609372 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66365528 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64614449 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63190893 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61131889 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.56781138 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56220389 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55626159 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55105936 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54585346 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54090047 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52553890 |
| 73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50887874 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50293886 |
| 75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49138854 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48739652 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46554130 |
| 78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42142845 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40661861 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39140808 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38868308 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38729463 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38011805 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36733208 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35700936 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.26713725 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.25139080 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.20479494 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.19969468 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.19242107 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18026419 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17159960 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16348007 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.16263379 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16198492 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.15987692 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.15438270 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.14334275 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13921262 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13861757 |

